Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Colorectal Neoplasms

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 175 articles:
HTML format



Single Articles


    September 2020
  1. WANG X, Tao G, Huang D, Liang S, et al
    Circular RNA NOX4 promotes the development of colorectal cancer via the microRNA4855p/CKS1B axis.
    Oncol Rep. 2020 Sep 7. doi: 10.3892/or.2020.7758.
    PubMed     Abstract available


  2. YANG H, Li Q, Wu Y, Dong J, et al
    Long noncoding RNA RP11400N13.3 promotes the progression of colorectal cancer by regulating the miR47223p/P2RY8 axis.
    Oncol Rep. 2020 Sep 7. doi: 10.3892/or.2020.7755.
    PubMed     Abstract available


  3. WEN L, Zhang X, Zhang J, Chen S, et al
    Paxillin knockdown suppresses metastasis and epithelialmesenchymal transition in colorectal cancer via the ERK signalling pathway.
    Oncol Rep. 2020;44:1105-1115.
    PubMed     Abstract available


  4. XU J, Chen Q, Tian K, Liang R, et al
    m6A methyltransferase METTL3 maintains colon cancer tumorigenicity by suppressing SOCS2 to promote cell proliferation.
    Oncol Rep. 2020;44:973-986.
    PubMed     Abstract available


  5. SUN LB, Zhao SF, Zhu JJ, Han Y, et al
    Long noncoding RNA UCID sponges miR1523p to promote colorectal cancer cell migration and invasion via the Wnt/betacatenin signaling pathway.
    Oncol Rep. 2020;44:1194-1205.
    PubMed     Abstract available


    August 2020
  6. JING L, Feng L, Zhou Z, Shi S, et al
    TNNT2 as a potential biomarker for the progression and prognosis of colorectal cancer.
    Oncol Rep. 2020;44:628-636.
    PubMed     Abstract available


  7. SHI DD, Yang CG, Han S, Wang SY, et al
    Dynamic evaluation of mesenchymal circulating tumor cells in patients with colorectal cancer: Clinical associations and prognostic value.
    Oncol Rep. 2020;44:757-767.
    PubMed     Abstract available


  8. HUANG C, He C, Ruan P, Zhou R, et al
    TSPYL5 activates endoplasmic reticulum stress to inhibit cell proliferation, migration and invasion in colorectal cancer.
    Oncol Rep. 2020;44:449-456.
    PubMed     Abstract available


    July 2020
  9. WANG W, Wang H, Xiang L, Ni T, et al
    DJ1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer.
    Oncol Rep. 2020;44:77-90.
    PubMed     Abstract available


    May 2020
  10. ZHAO J, Li G, Wei J, Dang S, et al
    Ellagic acid induces cell cycle arrest and apoptosis via the TGFbeta1/Smad3 signaling pathway in human colon cancer HCT116 cells.
    Oncol Rep. 2020 May 20. doi: 10.3892/or.2020.7617.
    PubMed     Abstract available


    April 2020
  11. LI P, He C, Gao A, Yan X, et al
    RAD18 promotes colorectal cancer metastasis by activating the epithelialmesenchymal transition pathway.
    Oncol Rep. 2020 Apr 21. doi: 10.3892/or.2020.7590.
    PubMed     Abstract available


  12. WANG H, Liu S, Kong F, Xiao F, et al
    Spred2 inhibits epithelialmesenchymal transition of colorectal cancer cells by impairing ERK signaling.
    Oncol Rep. 2020 Apr 16. doi: 10.3892/or.2020.7586.
    PubMed     Abstract available


    March 2020
  13. MATSUMOTO A, Shimada Y, Nakano M, Oyanagi H, et al
    RNF43 mutation is associated with aggressive tumor biology along with BRAF V600E mutation in right-sided colorectal cancer.
    Oncol Rep. 2020 Mar 23. doi: 10.3892/or.2020.7561.
    PubMed     Abstract available


    February 2020
  14. YAN X, Li M, Chen L, Peng X, et al
    alphaSolanine inhibits growth and metastatic potential of human colorectal cancer cells.
    Oncol Rep. 2020 Feb 26. doi: 10.3892/or.2020.7519.
    PubMed     Abstract available


  15. ZHANG NN, Lin T, Xiao M, Li QS, et al
    Transcriptome sequencing analysis of monoADPribosylation in colorectal cancer cells.
    Oncol Rep. 2020 Feb 24. doi: 10.3892/or.2020.7516.
    PubMed     Abstract available


  16. TONG G, Zhang G, Liu J, Zheng Z, et al
    Cutoff of 25% for Ki67 expression is a good classification tool for prognosis in colorectal cancer in the AJCC8 stratification.
    Oncol Rep. 2020 Feb 21. doi: 10.3892/or.2020.7511.
    PubMed     Abstract available


  17. ZHAN J, Tong J, Fu Q
    Long noncoding RNA LINC00858 promotes TP53wildtype colorectal cancer progression by regulating the microRNA253p/SMAD7 axis.
    Oncol Rep. 2020 Feb 18. doi: 10.3892/or.2020.7506.
    PubMed     Abstract available


  18. JIANG X, Li D, Wang G, Liu J, et al
    Thapsigargin promotes colorectal cancer cell migration through upregulation of lncRNA MALAT1.
    Oncol Rep. 2020 Feb 13. doi: 10.3892/or.2020.7502.
    PubMed     Abstract available


  19. ZHOU L, Sui H, Wang T, Jia R, et al
    Tanshinone IIA reduces secretion of proangiogenic factors and inhibits angiogenesis in human colorectal cancer.
    Oncol Rep. 2020 Feb 12. doi: 10.3892/or.2020.7498.
    PubMed     Abstract available


  20. HAO Q, Wang M, Sun NX, Zhu C, et al
    Sulforaphane suppresses carcinogenesis of colorectal cancer through the ERK/Nrf2UDP glucuronosyltransferase 1A metabolic axis activation.
    Oncol Rep. 2020 Feb 10. doi: 10.3892/or.2020.7495.
    PubMed     Abstract available


  21. QIAO PF, Yao L, Zeng ZL
    Catalpolmediated microRNA34a suppresses autophagy and malignancy by regulating SIRT1 in colorectal cancer.
    Oncol Rep. 2020 Feb 7. doi: 10.3892/or.2020.7494.
    PubMed     Abstract available


  22. WANG K, Zheng J, Yu J, Wu Y, et al
    Knockdown of MMP1 inhibits the progression of colorectal cancer by suppressing the PI3K/Akt/cmyc signaling pathway and EMT.
    Oncol Rep. 2020 Feb 6. doi: 10.3892/or.2020.7490.
    PubMed     Abstract available


  23. ZHANG Y, Huang WJ, Yang QR, Zhang HD, et al
    Cryopreserved biopsy tissues of rectal cancer liver metastasis for assessment of anticancer drug response in vitro and in vivo.
    Oncol Rep. 2020;43:405-414.
    PubMed     Abstract available


    January 2020
  24. CHEN Y, Yang Z, Deng B, Wu D, et al
    Interleukin 1beta/1RA axis in colorectal cancer regulates tumor invasion, proliferation and apoptosis via autophagy.
    Oncol Rep. 2020 Jan 22. doi: 10.3892/or.2020.7475.
    PubMed     Abstract available


  25. FENG Y, Ji D, Huang Y, Ji B, et al
    TGM3 functions as a tumor suppressor by repressing epithelialtomesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer.
    Oncol Rep. 2020 Jan 21. doi: 10.3892/or.2020.7474.
    PubMed     Abstract available


    December 2019
  26. HOU B, Li W, Li J, Ma J, et al
    Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.
    Oncol Rep. 2019 Dec 20. doi: 10.3892/or.2019.7442.
    PubMed     Abstract available


  27. LI FS, Huang J, Cui MZ, Zeng JR, et al
    BMP9 mediates the anticancer activity of evodiamine through HIF1alpha/p53 in human colon cancer cells.
    Oncol Rep. 2019 Dec 11. doi: 10.3892/or.2019.7427.
    PubMed     Abstract available


  28. KATO J, Shirakami Y, Ohnishi M, Mizutani T, et al
    Suppressive effects of the sodiumglucose cotransporter 2 inhibitor tofogliflozin on colorectal tumorigenesis in diabetic and obese mice.
    Oncol Rep. 2019;42:2797-2805.
    PubMed     Abstract available


  29. LIU H, Liu J, Huo J, Li K, et al
    Downregulation of miR143 modulates KRAS expression in colorectal carcinoma cells.
    Oncol Rep. 2019;42:2759-2767.
    PubMed     Abstract available


    November 2019
  30. QIAN Z, Gong L, Mou Y, Han Y, et al
    MicroRNA203a3p is a candidate tumor suppressor that targets thrombospondin 2 in colorectal carcinoma.
    Oncol Rep. 2019;42:1825-1832.
    PubMed     Abstract available


  31. LI JM, Jiang GM, Zhao L, Yang F, et al
    Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatinresistant cell line to oxaliplatin by inhibiting excision repair crosscomplementing group 1 protein expression.
    Oncol Rep. 2019;42:1725-1734.
    PubMed     Abstract available


    October 2019
  32. ISHIKAWA K, Kawano Y, Arihara Y, Kubo T, et al
    BH3 profiling discriminates the antiapoptotic status of 5fluorouracilresistant colon cancer cells.
    Oncol Rep. 2019 Oct 15. doi: 10.3892/or.2019.7373.
    PubMed     Abstract available


  33. LV Y, Xie B, Bai B, Shan L, et al
    Weighted gene coexpression analysis indicates that PLAGL2 and POFUT1 are related to the differential features of proximal and distal colorectal cancer.
    Oncol Rep. 2019 Oct 14. doi: 10.3892/or.2019.7368.
    PubMed     Abstract available


  34. WU B, Sun D, Ma L, Deng Y, et al
    Exosomes isolated from CAPS1overexpressing colorectal cancer cells promote cell migration.
    Oncol Rep. 2019 Oct 9. doi: 10.3892/or.2019.7361.
    PubMed     Abstract available


  35. NEGRI F, Bozzetti C, Pedrazzi G, Azzoni C, et al
    High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer.
    Oncol Rep. 2019 Oct 1. doi: 10.3892/or.2019.7349.
    PubMed     Abstract available


    September 2019
  36. DHO SH, Cho EH, Lee JY, Lee SY, et al
    A novel therapeutic antiCD55 monoclonal antibody inhibits the proliferation and metastasis of colorectal cancer cells.
    Oncol Rep. 2019 Sep 26. doi: 10.3892/or.2019.7337.
    PubMed     Abstract available


  37. RUAN GT, Gong YZ, Liao XW, Wang S, et al
    Diagnostic and prognostic values of CXC motif chemokine ligand 3 in patients with colon cancer.
    Oncol Rep. 2019 Sep 19. doi: 10.3892/or.2019.7326.
    PubMed     Abstract available


  38. SHU W, Liu G, Dai Y, Feng A, et al
    The oncogenic role of NKAP in the growth and invasion of colon cancer cells.
    Oncol Rep. 2019 Sep 18. doi: 10.3892/or.2019.7322.
    PubMed     Abstract available


  39. JIANG X, Shen TY, Lu H, Shi C, et al
    Clinical significance and biological role of KLF17 as a tumour suppressor in colorectal cancer.
    Oncol Rep. 2019 Sep 18. doi: 10.3892/or.2019.7324.
    PubMed     Abstract available


  40. LI Y, Xi Y, Zhu G, Jia J, et al
    Downregulated IGFBP7 facilitates liver metastasis by modulating epithelialmesenchymal transition in colon cancer.
    Oncol Rep. 2019 Sep 6. doi: 10.3892/or.2019.7303.
    PubMed     Abstract available


  41. SAWADA R, Arai Y, Sagawa Y, Nagata Y, et al
    High blood levels of soluble OX40 (CD134), an immune costimulatory molecule, indicate reduced survival in patients with advanced colorectal cancer.
    Oncol Rep. 2019 Sep 6. doi: 10.3892/or.2019.7304.
    PubMed     Abstract available


  42. TANAKAYA K, Kumamoto K, Tada Y, Eguchi H, et al
    A germline MBD4 mutation was identified in a patient with colorectal oligopolyposis and earlyonset cancer: A case report.
    Oncol Rep. 2019;42:1133-1140.
    PubMed     Abstract available


  43. GONG YZ, Ruan GT, Liao XW, Wang XK, et al
    Diagnostic and prognostic values of integrin alpha subfamily mRNA expression in colon adenocarcinoma.
    Oncol Rep. 2019;42:923-936.
    PubMed     Abstract available


    August 2019
  44. HONG HK, Pyo DH, Kim TW, Yun NH, et al
    Efficient primary culture model of patientderived tumor cells from colorectal cancer using a Rhoassociated protein kinase inhibitor and feeder cells.
    Oncol Rep. 2019 Aug 20. doi: 10.3892/or.2019.7285.
    PubMed     Abstract available


  45. LI J, He J, Wang Y, Shu Y, et al
    SMC1 promotes proliferation and inhibits apoptosis through the NFkappaB signaling pathway in colorectal cancer.
    Oncol Rep. 2019 Aug 8. doi: 10.3892/or.2019.7273.
    PubMed     Abstract available


  46. GU J, Wang L, Li T, Tang S, et al
    Role and mechanism of organic cation transporter 3 in oxaliplatin treatment of colon cancer in vitro and in vivo.
    Oncol Rep. 2019 Aug 7. doi: 10.3892/or.2019.7267.
    PubMed     Abstract available


  47. TONG J, Shen Y, Chen X, Wang R, et al
    FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression.
    Oncol Rep. 2019 Aug 2. doi: 10.3892/or.2019.7259.
    PubMed     Abstract available


  48. CHEN L, Chen L, Wan L, Huo Y, et al
    Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3alpha signaling pathway in C2C12 myotubes and mice.
    Oncol Rep. 2019;42:479-494.
    PubMed     Abstract available


    July 2019
  49. TANAKA E, Miyakawa Y, Kishikawa T, Seimiya T, et al
    Expression of circular RNA CDR1AS in colon cancer cells increases cell surface PDL1 protein levels.
    Oncol Rep. 2019 Jul 19. doi: 10.3892/or.2019.7244.
    PubMed     Abstract available


  50. LI H, Lai Z, Yang H, Peng J, et al
    Hedyotis diffusa Willd. inhibits VEGFCmediated lymphangiogenesis in colorectal cancer via multiple signaling pathways.
    Oncol Rep. 2019 Jul 5. doi: 10.3892/or.2019.7223.
    PubMed     Abstract available


  51. CHEN Y, Yang Z, Wu D, Min Z, et al
    Upregulation of interleukin17F in colorectal cancer promotes tumor invasion by inducing epithelialmesenchymal transition.
    Oncol Rep. 2019 Jul 4. doi: 10.3892/or.2019.7220.
    PubMed     Abstract available


  52. WANG Y, Zhou L, Qing Q, Li Y, et al
    Gene expression profile of cancer stemlike cells in the SW480 colon adenocarcinoma cell line.
    Oncol Rep. 2019;42:386-398.
    PubMed     Abstract available


  53. ANDO N, Hara M, Shiga K, Yanagita T, et al
    Eicosapentaenoic acid suppresses angiogenesis via reducing secretion of IL6 and VEGF from colon cancerassociated fibroblasts.
    Oncol Rep. 2019;42:339-349.
    PubMed     Abstract available


    May 2019
  54. XIONG W, Wang X, Cai X, Xiong W, et al
    Identification of tRNAderived fragments in colon cancer by comprehensive small RNA sequencing.
    Oncol Rep. 2019 May 31. doi: 10.3892/or.2019.7178.
    PubMed     Abstract available


  55. WAN Z, Chai R, Yuan H, Chen B, et al
    MEIS2 promotes cell migration and invasion in colorectal cancer.
    Oncol Rep. 2019 May 15. doi: 10.3892/or.2019.7161.
    PubMed     Abstract available


  56. YIN J, Qi W, Ji CG, Zhang DX, et al
    Small RNA sequencing revealed aberrant piRNA expression profiles in colorectal cancer.
    Oncol Rep. 2019 May 13. doi: 10.3892/or.2019.7158.
    PubMed     Abstract available


  57. KITAGAWA H, Kitajima Y, Kai K, Komukai S, et al
    Predictive value of the ratio of 8hydroxydeoxyguanosine levels between cancerous and normal tissues in patients with stage II/III colorectal cancer.
    Oncol Rep. 2019;41:3041-3050.
    PubMed     Abstract available


  58. QIAN W, Feng Y, Li J, Peng W, et al
    Construction of ceRNA networks reveals differences between distal and proximal colon cancers.
    Oncol Rep. 2019;41:3027-3040.
    PubMed     Abstract available


  59. BANH T, Snoke D, Cole RM, Angelotti A, et al
    Higher tumor mass and lower adipose mass are associated with colon26 adenocarcinomainduced cachexia in male, female and ovariectomized mice.
    Oncol Rep. 2019;41:2909-2918.
    PubMed     Abstract available


  60. WANG JQ, Tang Y, Li QS, Xiao M, et al
    PARG regulates the proliferation and differentiation of DCs and T cells via PARP/NFkappaB in tumour metastases of colon carcinoma.
    Oncol Rep. 2019;41:2657-2666.
    PubMed     Abstract available


    April 2019
  61. YAO Y, Rao C, Zheng G, Wang S, et al
    Luteolin suppresses colorectal cancer cell metastasis via regulation of the miR384/pleiotrophin axis.
    Oncol Rep. 2019 Apr 24. doi: 10.3892/or.2019.7136.
    PubMed     Abstract available


  62. SHIRATORI H, Kawai K, Hata K, Tanaka T, et al
    The combination of temsirolimus and chloroquine increases radiosensitivity in colorectal cancer cells.
    Oncol Rep. 2019 Apr 23. doi: 10.3892/or.2019.7134.
    PubMed     Abstract available


  63. JIANG J, Li Y, Jiang Z
    Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/beta-catenin signaling pathway.
    Oncol Rep. 2019 Apr 17. doi: 10.3892/or.2019.7126.
    PubMed     Abstract available


  64. XU C, Yu X, Zhu Y, Cai Z, et al
    Overexpression of calpain1 predicts poor outcome in patients with colorectal cancer and promotes tumor cell progression associated with downregulation of FLNA.
    Oncol Rep. 2019 Apr 16. doi: 10.3892/or.2019.7121.
    PubMed     Abstract available


  65. ZHANG H, Song Y, Yang C, Wu X, et al
    Overexpression of lncRNA TUSC7 reduces cell migration and invasion in colorectal cancer.
    Oncol Rep. 2019 Apr 9. doi: 10.3892/or.2019.7106.
    PubMed     Abstract available


    March 2019
  66. CHENG Z, Shao X, Xu M, Wang J, et al
    Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.
    Oncol Rep. 2019 Mar 15. doi: 10.3892/or.2019.7071.
    PubMed     Abstract available


  67. ZHANG T, Liu L, Lai W, Zeng Y, et al
    Interaction with tumorassociated macrophages promotes PRL3induced invasion of colorectal cancer cells via MAPK pathwayinduced EMT and NFkappaB signalinginduced angiogenesis.
    Oncol Rep. 2019 Mar 7. doi: 10.3892/or.2019.7049.
    PubMed     Abstract available


    February 2019
  68. NAGASU S, Sudo T, Kinugasa T, Yomoda T, et al
    Yboxbinding protein 1 inhibits apoptosis and upregulates EGFR in colon cancer.
    Oncol Rep. 2019 Feb 28. doi: 10.3892/or.2019.7038.
    PubMed     Abstract available


  69. XU J, Qian J, Zhang W, Chen E, et al
    LYPD8 regulates the proliferation and migration of colorectal cancer cells through inhibiting the secretion of IL6 and TNFalpha.
    Oncol Rep. 2019 Feb 26. doi: 10.3892/or.2019.7034.
    PubMed     Abstract available


  70. JIANG Y, Cai Y, Shao W, Li F, et al
    MicroRNA144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in colorectal cancer.
    Oncol Rep. 2019 Feb 21. doi: 10.3892/or.2019.7025.
    PubMed     Abstract available


  71. ALCANTARA KMM, Garcia RL
    MicroRNA92a promotes cell proliferation, migration and survival by directly targeting the tumor suppressor gene NF2 in colorectal and lung cancer cells.
    Oncol Rep. 2019 Feb 19. doi: 10.3892/or.2019.7020.
    PubMed     Abstract available


    January 2019
  72. LV Z, He K, Shi L, Shi K, et al
    Interaction between C2ORF68 and HuR in human colorectal cancer.
    Oncol Rep. 2019 Jan 21. doi: 10.3892/or.2019.6973.
    PubMed     Abstract available


  73. TIAN W, Du Y, Ma Y, Zhang B, et al
    miR663aTTC22V1 axis inhibits colon cancer metastasis.
    Oncol Rep. 2019 Jan 16. doi: 10.3892/or.2019.6969.
    PubMed     Abstract available


    December 2018
  74. GUO L, Ma L, Liu C, Lei Y, et al
    ERp29 counteracts the suppression of malignancy mediated by endoplasmic reticulum stress and promotes the metastasis of colorectal cancer.
    Oncol Rep. 2018 Dec 19. doi: 10.3892/or.2018.6943.
    PubMed     Abstract available


  75. RYU TY, Kim K, Son MY, Min JK, et al
    Downregulation of PRMT1, a histone arginine methyltransferase, by sodium propionate induces cell apoptosis in colon cancer.
    Oncol Rep. 2018 Dec 18. doi: 10.3892/or.2018.6938.
    PubMed     Abstract available


  76. LI N, Li D, Du Y, Su C, et al
    Overexpressed PLAGL2 transcriptionally activates Wnt6 and promotes cancer development in colorectal cancer.
    Oncol Rep. 2018 Dec 7. doi: 10.3892/or.2018.6914.
    PubMed     Abstract available


    November 2018
  77. MARQUEZ J, Kratchmarova I, Akimov V, Unda F, et al
    NADH dehydrogenase complex I is overexpressed in incipient metastatic murine colon cancer cells.
    Oncol Rep. 2018 Nov 27. doi: 10.3892/or.2018.6892.
    PubMed     Abstract available


  78. KITAMURA H, Takemura H, Minamoto T
    Tumor p16INK4 gene expression and prognosis in colorectal cancer.
    Oncol Rep. 2018 Nov 26. doi: 10.3892/or.2018.6884.
    PubMed     Abstract available


  79. CHEN Y, Liu Y, Zhou Y, You H, et al
    Molecular mechanism of LKB1 in the invasion and metastasis of colorectal cancer.
    Oncol Rep. 2018 Nov 21. doi: 10.3892/or.2018.6877.
    PubMed     Abstract available


  80. MA Y, Chen Y, Lin C, Hu G, et al
    Biological functions and clinical significance of the newly identified long noncoding RNA RP185F18.6 in colorectal cancer.
    Oncol Rep. 2018;40:2648-2658.
    PubMed     Abstract available


  81. AKAGI J, Baba H
    Hydrogen gas restores exhausted CD8+ T cells in patients with advanced colorectal cancer to improve prognosis.
    Oncol Rep. 2018 Nov 1. doi: 10.3892/or.2018.6841.
    PubMed     Abstract available


  82. ZHANG T, Guo J, Gu J, Wang Z, et al
    Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Oncol Rep. 2018 Nov 1. doi: 10.3892/or.2018.6840.
    PubMed     Abstract available


    October 2018
  83. AI X, Lei Q, Shen X, Li J, et al
    Long noncoding RNA ENST00000547547 inhibits cell proliferation, invasion and migration in colorectal cancer cells.
    Oncol Rep. 2018 Oct 31. doi: 10.3892/or.2018.6834.
    PubMed     Abstract available


  84. TANG B, Liang W, Liao Y, Li Z, et al
    PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway.
    Oncol Rep. 2018 Oct 25. doi: 10.3892/or.2018.6825.
    PubMed     Abstract available


  85. MUN JG, Kee JY, Han YH, Lee S, et al
    Galla Rhois water extract inhibits lung metastasis by inducing AMPKmediated apoptosis and suppressing metastatic properties of colorectal cancer cells.
    Oncol Rep. 2018 Oct 22. doi: 10.3892/or.2018.6812.
    PubMed     Abstract available


  86. ZHANG Z, Zhong X, Xiao Y, Chen C, et al
    MicroRNA-296 inhibits colorectal cancer cell growth and enhances apoptosis by targeting ARRB1-mediated AKT activation.
    Oncol Rep. 2018 Oct 18. doi: 10.3892/or.2018.6806.
    PubMed     Abstract available


  87. DING L, Gu H, Lan Z, Lei Q, et al
    Downregulation of cyclooxygenase1 stimulates mitochondrial apoptosis through the NFkappaB signaling pathway in colorectal cancer cells.
    Oncol Rep. 2018 Oct 12. doi: 10.3892/or.2018.6785.
    PubMed     Abstract available


  88. WU J, Zhao R, Lin J, Liu B, et al
    Integrin beta4 reduces DNA damageinduced p53 activation in colorectal cancer.
    Oncol Rep. 2018;40:2183-2192.
    PubMed     Abstract available


  89. LIU BS, Xia HW, Zhou S, Liu Q, et al
    Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells.
    Oncol Rep. 2018;40:2171-2182.
    PubMed     Abstract available


  90. QIAO P, Li S, Zhang H, Yao L, et al
    Farnesoid X receptor inhibits proliferation of human colorectal cancer cells via the miR135A1/CCNG2 signaling pathway.
    Oncol Rep. 2018;40:2067-2078.
    PubMed     Abstract available


  91. ALSAMMAN K, El-Masry OS
    Staurosporine alleviates cisplatin chemoresistance in human cancer cell models by suppressing the induction of SQSTM1/p62.
    Oncol Rep. 2018;40:2157-2162.
    PubMed     Abstract available


  92. WEI HT, Guo EN, Liao XW, Chen LS, et al
    Genomescale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
    Oncol Rep. 2018;40:1947-1958.
    PubMed     Abstract available


    September 2018
  93. CHEN Y, Huang Y, Lu X, Wang G, et al
    Antitumor effects of the silencing of programmed cell death ligand 1 in colorectal cancer via immunoregulation.
    Oncol Rep. 2018 Sep 26. doi: 10.3892/or.2018.6738.
    PubMed     Abstract available


  94. XIE B, Zhao R, Bai B, Wu Y, et al
    Identification of key tumorigenesisrelated genes and their microRNAs in colon cancer.
    Oncol Rep. 2018 Sep 21. doi: 10.3892/or.2018.6726.
    PubMed     Abstract available


  95. JANG SW, Park WJ, Min H, Kwon TK, et al
    Altered mRNA expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer.
    Oncol Rep. 2018 Sep 18. doi: 10.3892/or.2018.6712.
    PubMed     Abstract available


  96. LIN WC, Wang WH, Lin YH, Leu JD, et al
    Synergistic effects of tetrandrine combined with ionizing radiation on a murine colorectal carcinomabearing mouse model.
    Oncol Rep. 2018;40:1390-1400.
    PubMed     Abstract available


    August 2018
  97. ZHOU N, Sun Z, Li N, Ge Y, et al
    miR197 promotes the invasion and migration of colorectal cancer by targeting insulinlike growth factorbinding protein 3.
    Oncol Rep. 2018 Aug 10. doi: 10.3892/or.2018.6640.
    PubMed     Abstract available


  98. LU J, Zhang L, Zhou H, Du Z, et al
    Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
    Oncol Rep. 2018;40:887-894.
    PubMed     Abstract available


  99. PENG W, Tan S, Xu Y, Wang L, et al
    LCMS/MS metabolome analysis detects the changes in the lipid metabolic profiles of dMMR and pMMR cells.
    Oncol Rep. 2018;40:1026-1034.
    PubMed     Abstract available


    July 2018
  100. NIE S, Huang Y, Shi M, Qian X, et al
    Protective role of ABCG2 against oxidative stress in colorectal cancer and its potential underlying mechanism.
    Oncol Rep. 2018 Jul 24. doi: 10.3892/or.2018.6594.
    PubMed     Abstract available


  101. JI B, Feng Y, Sun Y, Ji D, et al
    GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelialmesenchymal transition through PI3K/AKT signaling activation.
    Oncol Rep. 2018 Jul 20. doi: 10.3892/or.2018.6582.
    PubMed     Abstract available


  102. CHENG K, Zhao Z, Wang G, Wang J, et al
    lncRNA GAS5 inhibits colorectal cancer cell proliferation via the miR1825p/FOXO3a axis.
    Oncol Rep. 2018 Jul 20. doi: 10.3892/or.2018.6584.
    PubMed     Abstract available


  103. LI JW, Huang CZ, Li JH, Yuan JH, et al
    Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.
    Oncol Rep. 2018 Jul 17. doi: 10.3892/or.2018.6581.
    PubMed     Abstract available


  104. YANG X, Liu W, Xu X, Zhu J, et al
    Downregulation of long noncoding RNA UCA1 enhances the radiosensitivity and inhibits migration via suppression of epithelialmesenchymal transition in colorectal cancer cells.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6573.
    PubMed     Abstract available


  105. JIANG T, Li H, Jiang R, Li H, et al
    Pin2/TRF1binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factorkappaB signaling pathway.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6570.
    PubMed     Abstract available


  106. IIDA M, Hazama S, Tsunedomi R, Tanaka H, et al
    Overexpression of miR221 and miR222 in the cancer stroma is associated with malignant potential in colorectal cancer.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6575.
    PubMed     Abstract available


  107. SONG J, Wang L, Ma Q, Yang Y, et al
    Let7i5p inhibits the proliferation and metastasis of colon cancer cells by targeting kallikreinrelated peptidase 6.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6577.
    PubMed     Abstract available


  108. LI Y, Xin S, Wu H, Xing C, et al
    High expression of microRNA31 and its host gene LOC554202 predict favorable outcomes in patients with colorectal cancer treated with oxaliplatin.
    Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6571.
    PubMed     Abstract available


  109. FENG Y, Dong YW, Song YN, Xiao JH, et al
    MicroRNA449a is a potential predictor of colitisassociated colorectal cancer progression.
    Oncol Rep. 2018 Jul 12. doi: 10.3892/or.2018.6566.
    PubMed     Abstract available


  110. ZHANG H, Deng Z, Zhang D, Li H, et al
    High expression of leucinerich repeatcontaining 8A is indicative of a worse outcome of colon cancer patients by enhancing cancer cell growth and metastasis.
    Oncol Rep. 2018 Jul 10. doi: 10.3892/or.2018.6556.
    PubMed     Abstract available


  111. XU Y, Liu X, Zhang H, Zhu Z, et al
    Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/beta-catenin signaling pathway in colorectal cancer.
    Oncol Rep. 2018 Jul 2. doi: 10.3892/or.2018.6539.
    PubMed     Abstract available


  112. BI C, Jiang B
    Downregulation of RPN2 induces apoptosis and inhibits migration and invasion in colon carcinoma.
    Oncol Rep. 2018;40:283-293.
    PubMed     Abstract available


    June 2018
  113. LIU M, Zhang X, Cai J, Li Y, et al
    Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion.
    Oncol Rep. 2018 Jun 26. doi: 10.3892/or.2018.6525.
    PubMed     Abstract available


  114. GUO Y, Wang M, Jia X, Zhu H, et al
    Wnt signaling pathway upregulates DNMT1 to trigger NHERF1 promoter hypermethylation in colon cancer.
    Oncol Rep. 2018 Jun 14. doi: 10.3892/or.2018.6494.
    PubMed     Abstract available


  115. ZHANG Y, Wang S, Qian W, Ji D, et al
    uc.338 targets p21 and cyclin D1 via PI3K/AKT pathway activation to promote cell proliferation in colorectal cancer.
    Oncol Rep. 2018 Jun 7. doi: 10.3892/or.2018.6480.
    PubMed     Abstract available


  116. NIKOLOUZAKIS TK, Vassilopoulou L, Fragkiadaki P, Mariolis Sapsakos T, et al
    Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review).
    Oncol Rep. 2018;39:2455-2472.
    PubMed     Abstract available


    May 2018
  117. TAMURA S, Isobe T, Ariyama H, Nakano M, et al
    Ecadherin regulates proliferation of colorectal cancer stem cells through NANOG.
    Oncol Rep. 2018 May 24. doi: 10.3892/or.2018.6464.
    PubMed     Abstract available


  118. ZHU D, Sun Y, Zhang D, Dong M, et al
    miR1 inhibits the progression of colon cancer by regulating the expression of vascular endothelial growth factor.
    Oncol Rep. 2018 May 24. doi: 10.3892/or.2018.6463.
    PubMed     Abstract available


  119. MENG Q, Chen Y, Lian B, Shang Y, et al
    miR218 promotes apoptosis of SW1417 human colon cancer cells by targeting cFLIP.
    Oncol Rep. 2018 May 23. doi: 10.3892/or.2018.6460.
    PubMed     Abstract available


  120. ALQURASHI N, Hashimi SM, Alowaidi F, Ivanovski S, et al
    Dual mTOR/PI3K inhibitor NVPBEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4EBP1.
    Oncol Rep. 2018 May 22. doi: 10.3892/or.2018.6457.
    PubMed     Abstract available


  121. CUI X, Wang G, Shen W, Huang Z, et al
    Lysyl oxidase-like 2 is highly expressed in colorectal cancer cells and promotes the development of colorectal cancer.
    Oncol Rep. 2018 May 21. doi: 10.3892/or.2018.6452.
    PubMed     Abstract available


  122. ZHENG LZ, Chen SZ
    shRNAinduced knockdown of the SPERT gene inhibits proliferation and promotes apoptosis of human colorectal cancer RKO cells.
    Oncol Rep. 2018 May 21. doi: 10.3892/or.2018.6455.
    PubMed     Abstract available


  123. LI J, Xu J, Yan X, Jin K, et al
    MicroRNA-485 plays tumour-suppressive roles in colorectal cancer by directly targeting GAB2.
    Oncol Rep. 2018 May 17. doi: 10.3892/or.2018.6449.
    PubMed     Abstract available


  124. YANG H, Wang S, Kang YJ, Wang C, et al
    Long non-coding RNA SNHG1 predicts a poor prognosis and promotes colon cancer tumorigenesis.
    Oncol Rep. 2018 May 2. doi: 10.3892/or.2018.6412.
    PubMed     Abstract available


  125. MAO L, Chen Q, Gong K, Xu X, et al
    Berberine decelerates glucose metabolism via suppression of mTORdependent HIF1alpha protein synthesis in colon cancer cells.
    Oncol Rep. 2018;39:2436-2442.
    PubMed     Abstract available


  126. YU Y, Peng K, Li H, Zhuang R, et al
    SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer.
    Oncol Rep. 2018;39:2235-2242.
    PubMed     Abstract available


  127. XING Y, Zhao Z, Zhu Y, Zhao L, et al
    Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Oncol Rep. 2018;39:2365-2375.
    PubMed     Abstract available


  128. LI K, Guo J, Wu Y, Jin D, et al
    Suppression of YAP by DDP disrupts colon tumor progression.
    Oncol Rep. 2018;39:2114-2126.
    PubMed     Abstract available


  129. ZHANG Z, Wang S, Ji D, Qian W, et al
    Construction of a ceRNA network reveals potential lncRNA biomarkers in rectal adenocarcinoma.
    Oncol Rep. 2018;39:2101-2113.
    PubMed     Abstract available


    April 2018
  130. LI C, Du X, Xia S, Chen L, et al
    MicroRNA-150 inhibits the proliferation and metastasis potential of colorectal cancer cells by targeting iASPP.
    Oncol Rep. 2018 Apr 30. doi: 10.3892/or.2018.6406.
    PubMed     Abstract available


  131. FUJINO S, Kinugasa T, Sudo T, Mizobe T, et al
    Mina53 nuclear localization is an important indicator of prognosis in patients with colorectal cancer after adjuvant chemotherapy.
    Oncol Rep. 2018 Apr 30. doi: 10.3892/or.2018.6407.
    PubMed     Abstract available


  132. TERASAKI M, Mima M, Kudoh S, Endo T, et al
    Glycine and succinic acid are effective indicators of the suppression of epithelial-mesenchymal transition by fucoxanthinol in colorectal cancer stem-like cells.
    Oncol Rep. 2018 Apr 24. doi: 10.3892/or.2018.6398.
    PubMed     Abstract available


  133. ALOWAIDI F, Hashimi SM, Alqurashi N, Alhulais R, et al
    Assessing stemness and proliferation properties of the newly established colon cancer 'stem' cell line, CSC480 and novel approaches to identify dormant cancer cells.
    Oncol Rep. 2018 Apr 23. doi: 10.3892/or.2018.6392.
    PubMed     Abstract available


  134. CHEN S, Zhang L, Su Y, Zhang X, et al
    Screening potential biomarkers for colorectal cancer based on circular RNA chips.
    Oncol Rep. 2018 Apr 16. doi: 10.3892/or.2018.6372.
    PubMed     Abstract available


  135. JEONG D, Kim H, Kim D, Ban S, et al
    Protein kinase, membraneassociated tyrosine/threonine 1 is associated with the progression of colorectal cancer.
    Oncol Rep. 2018 Apr 13. doi: 10.3892/or.2018.6371.
    PubMed     Abstract available


  136. BENEDICTO A, Romayor I, Arteta B
    CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver.
    Oncol Rep. 2018;39:2022-2030.
    PubMed     Abstract available


  137. PARK JH, Lee JM, Lee EJ, Kim DJ, et al
    Kynurenine promotes the goblet cell differentiation of HT-29 colon carcinoma cells by modulating Wnt, Notch and AhR signals.
    Oncol Rep. 2018;39:1930-1938.
    PubMed     Abstract available


    March 2018
  138. REN W, Wang T, He X, Zhang Q, et al
    betaarrestin2 promotes 5FUinduced apoptosis via the NFkappaB pathway in colorectal cancer.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6340.
    PubMed     Abstract available


  139. LIU W, Li L, Ye H, Tao H, et al
    Role of COL6A3 in colorectal cancer.
    Oncol Rep. 2018 Mar 23. doi: 10.3892/or.2018.6331.
    PubMed     Abstract available


  140. PAN Y, Sun H, Hu X, He B, et al
    The inhibitory role of miR4855p in colorectal cancer proliferation and invasion via targeting of CD147.
    Oncol Rep. 2018 Mar 12. doi: 10.3892/or.2018.6309.
    PubMed     Abstract available


  141. QI C, Chen Y, Zhou Y, Huang X, et al
    Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Oncol Rep. 2018 Mar 8. doi: 10.3892/or.2018.6303.
    PubMed     Abstract available


  142. FUJINO S, Miyoshi N, Ohue M, Takahashi Y, et al
    Plateletderived growth factor receptorbeta gene expression relates to recurrence in colorectal cancer.
    Oncol Rep. 2018 Mar 1. doi: 10.3892/or.2018.6290.
    PubMed     Abstract available


  143. PARK HS, Kim BC, Yeo HY, Kim KH, et al
    Deleted in malignant brain tumor 1 is a novel prognostic marker in colorectal cancer.
    Oncol Rep. 2018 Mar 1. doi: 10.3892/or.2018.6287.
    PubMed     Abstract available


  144. KANEKIYO S, Hazama S, Takenouchi H, Nakajima M, et al
    IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides.
    Oncol Rep. 2018 Mar 1. doi: 10.3892/or.2018.6288.
    PubMed     Abstract available


  145. ZENG X, Chen S, Lin Y, Ke Z, et al
    Acylated and unacylated ghrelin inhibit apoptosis in myoblasts cocultured with colon carcinoma cells.
    Oncol Rep. 2018;39:1387-1395.
    PubMed     Abstract available


  146. LIAO W, Li G, You Y, Wan H, et al
    Antitumor activity of Notch1 inhibition in human colorectal carcinoma cells.
    Oncol Rep. 2018;39:1063-1071.
    PubMed     Abstract available


    February 2018
  147. OKUGAWA Y, Yao L, Toiyama Y, Yamamoto A, et al
    Prognostic impact of sarcopenia and its correlation with circulating miR-21 in colorectal cancer patients.
    Oncol Rep. 2018 Feb 14. doi: 10.3892/or.2018.6270.
    PubMed     Abstract available


  148. LI Y, Zhao L, Zhang Y, Guan L, et al
    Downregulation of the long non-coding RNA XLOC_010588 inhibits the invasion and migration of colorectal cancer.
    Oncol Rep. 2018 Feb 12. doi: 10.3892/or.2018.6260.
    PubMed     Abstract available


  149. SHEN L, Dong X, Wang Y, Qiu L, et al
    beta3GnT8 regulates oxaliplatin resistance by altering integrin beta1 glycosylation in colon cancer cells.
    Oncol Rep. 2018 Feb 1. doi: 10.3892/or.2018.6243.
    PubMed     Abstract available


    January 2018
  150. ENDO S, Fujita M, Yamada S, Imadome K, et al
    Fra1 enhances the radioresistance of colon cancer cells to Xray or Cion radiation.
    Oncol Rep. 2018 Jan 19. doi: 10.3892/or.2018.6223.
    PubMed     Abstract available


  151. XIONG Y, Wang J, Zhu H, Liu L, et al
    Chronic oxymatrine treatment induces resistance and epithelialmesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.
    Oncol Rep. 2018 Jan 10. doi: 10.3892/or.2018.6204.
    PubMed     Abstract available


  152. GONG H, Fang L, Li Y, Du J, et al
    miR873 inhibits colorectal cancer cell proliferation by targeting TRAF5 and TAB1.
    Oncol Rep. 2018 Jan 8. doi: 10.3892/or.2018.6199.
    PubMed     Abstract available


  153. KIM IH, Nam TJ
    Fucoidan downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.
    Oncol Rep. 2018 Jan 4. doi: 10.3892/or.2018.6193.
    PubMed     Abstract available


  154. SHIMADA T, Tsuruta M, Hasegawa H, Okabayashi K, et al
    Heat shock protein 27 knockdown using nucleotidebased therapies enhances sensitivity to 5-FU chemotherapy in SW480 human colon cancer cells.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6180.
    PubMed     Abstract available


  155. PHILLIPS E, Horniblow RD, Poole V, Bedford M, et al
    A potential role for hepcidin in obesity-driven colorectal tumourigenesis.
    Oncol Rep. 2018;39:392-400.
    PubMed     Abstract available


  156. WOHLLEBEN G, Hauff K, Gasser M, Waaga-Gasser AM, et al
    Hypoxia induces differential expression patterns of osteopontin and CD44 in colorectal carcinoma.
    Oncol Rep. 2018;39:442-448.
    PubMed     Abstract available


  157. WANG Y, Xia C, Lun Z, Lv Y, et al
    Crosstalk between p38 MAPK and caspase-9 regulates mitochondria-mediated apoptosis induced by tetra-alpha-(4-carboxyphenoxy) phthalocyanine zinc photodynamic therapy in LoVo cells.
    Oncol Rep. 2018;39:61-70.
    PubMed     Abstract available


    December 2017
  158. ZHAO J, Xu J, Zhang R
    MicroRNA-411 inhibits malignant biological behaviours of colorectal cancer cells by directly targeting PIK3R3.
    Oncol Rep. 2017 Dec 5. doi: 10.3892/or.2017.6135.
    PubMed     Abstract available


  159. YANG C, Wang MH, Zhou JD, Chi Q, et al
    Upregulation of miR-542-3p inhibits the growth and invasion of human colon cancer cells through PI3K/AKT/survivin signaling.
    Oncol Rep. 2017;38:3545-3553.
    PubMed     Abstract available


    November 2017
  160. CHEN M, Lin M, Wang X
    Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
    Oncol Rep. 2017 Nov 24. doi: 10.3892/or.2017.6110.
    PubMed     Abstract available


  161. RATTANAWONG A, Payon V, Limpanasittikul W, Boonkrai C, et al
    Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6084.
    PubMed     Abstract available


  162. LIN CS, Liu LT, Ou LH, Pan SC, et al
    Role of mitochondrial function in the invasiveness of human colon cancer cells.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6087.
    PubMed     Abstract available


  163. LI J, Li X, Cen C, Ai X, et al
    The long non-coding RNA ENST00000547547 reduces 5-fluorouracil resistance of colorectal cancer cells via competitive binding to microRNA-31.
    Oncol Rep. 2017 Nov 7. doi: 10.3892/or.2017.6082.
    PubMed     Abstract available


  164. WANG D, Rai B, Qi F, Liu T, et al
    Influence of the Twist gene on the invasion and metastasis of colon cancer.
    Oncol Rep. 2017 Nov 6. doi: 10.3892/or.2017.6076.
    PubMed     Abstract available


    October 2017
  165. ZHANG Y, Guo Y, Wang M, Dong H, et al
    Quercetrin from Toona sinensis leaves induces cell cycle arrest and apoptosis via enhancement of oxidative stress in human colorectal cancer SW620 cells.
    Oncol Rep. 2017 Oct 17. doi: 10.3892/or.2017.6042.
    PubMed     Abstract available


  166. QUE K, Tong Y, Que G, Li L, et al
    Downregulation of miR-874-3p promotes chemotherapeutic resistance in colorectal cancer via inactivation of the Hippo signaling pathway.
    Oncol Rep. 2017 Oct 17. doi: 10.3892/or.2017.6041.
    PubMed     Abstract available


  167. HE PY, Yip WK, Chai BL, Chai BY, et al
    Inhibition of cell migration and invasion by miR29a3p in a colorectal cancer cell line through suppression of CDC42BPA mRNA expression.
    Oncol Rep. 2017 Oct 16. doi: 10.3892/or.2017.6037.
    PubMed     Abstract available


  168. TIAN XQ, Guo FF, Sun DF, Wang YC, et al
    Downregulation of ZNF278 arrests the cell cycle and decreases the proliferation of colorectal cancer cells via inhibition of the ERK/MAPK pathway.
    Oncol Rep. 2017 Oct 12. doi: 10.3892/or.2017.6031.
    PubMed     Abstract available


  169. LI X, Yang H, Ke J, Liu B, et al
    Smad4 re-expression increases the sensitivity to parthenolide in colorectal cancer.
    Oncol Rep. 2017;38:2317-2324.
    PubMed     Abstract available


  170. WU S, Wu F, Jiang Z
    Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer.
    Oncol Rep. 2017;38:2043-2050.
    PubMed     Abstract available


    September 2017
  171. LI K, Na K, Sang T, Wu K, et al
    The ethanol extracts of sporoderm-broken spores of Ganoderma lucidum inhibit colorectal cancer in vitro and in vivo.
    Oncol Rep. 2017 Sep 27. doi: 10.3892/or.2017.6010.
    PubMed     Abstract available


  172. LIU X, Wang Y, Zhao J
    MicroRNA337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
    Oncol Rep. 2017 Sep 25. doi: 10.3892/or.2017.5997.
    PubMed     Abstract available


  173. LI Y, Wang C, Li D, Deng P, et al
    1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice.
    Oncol Rep. 2017 Sep 13. doi: 10.3892/or.2017.5954.
    PubMed     Abstract available


  174. FEI R, Zhang Y, Wang S, Xiang T, et al
    alpha7 nicotinic acetylcholine receptor in tumor-associated macrophages inhibits colorectal cancer metastasis through the JAK2/STAT3 signaling pathway.
    Oncol Rep. 2017 Sep 4. doi: 10.3892/or.2017.5935.
    PubMed     Abstract available


    May 2017
  175. ANUPAMA S, Laha P, Sharma M, Pathak K, et al
    Pharmacokinetics, biodistribution and antitumour effects of Sclerotium rolfsii lectin in mice.
    Oncol Rep. 2017;37:2803-2810.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: